revealed that MYC amplification was associated with low immune infiltration of triple-negative breast cancer and that MYC may be involved in immune escape of triple-negative breast cancer by Multi-Omics Profiling (61). This evidence concerns the gene MYC and triple-negative breast carcinoma.